Westmount Partners, LLC

Position in BMY — Bristol Myers Squibb Co

CIK 2051491 LOS ANGELES, CA

Position in BMY

as of Jun 30, 2026 · filed Jul 7, 2026 Compact

Position Value

$586,859

-$41,899 QoQ

Shares Held

10,185

-1.8% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.19%

of 13F equity value

Holder Rank

#1,437

of 2,506 holders

Holding Since

Dec 2022

15 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Westmount Partners, LLC holds $10,104,775 across 9 Drug Manufacturers - General names. BMY ranks #6 (5.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	2,289	$2,745,495
2	JNJ	Johnson & Johnson	9,734	$2,472,143
3	ABBV	AbbVie Inc.	5,727	$1,441,142
4	AMGN	Amgen Inc	3,735	$1,352,518
5	MRK	Merck & Co., Inc.	5,013	$644,170
6	BMY	Bristol Myers Squibb Co This page	10,185	$586,859
7	GILD	Gilead Sciences, Inc.	2,887	$364,743
8	PFE	Pfizer Inc	10,594	$255,103

15 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$586,859	10,185	-1.8%	Shares	Sole	2026-07-07
2026-03-31	$628,758	10,367	+0.1%	Shares	Sole	2026-04-16
2025-12-31	$558,602	10,356	-0.5%	Shares	Sole	2026-01-15
2025-09-30	$469,400	10,408	+0.1%	Shares	Sole	2025-10-14
2025-06-30	$481,184	10,395	+0.1%	Shares	Sole	2025-07-09
2025-03-31	$633,320	10,384	+0.1%	Shares	Sole	2025-05-01
2024-12-31	$586,810	10,375	+0.1%	Shares	Sole	2025-01-13
2024-09-30	$536,285	10,365	-1.0%	Shares	Sole	2025-01-13
2024-06-30	$434,611	10,465	+1.2%	Shares	Sole	2025-01-28
2024-03-31	$560,846	10,342	-1.8%	Shares	Sole	2025-01-28
2023-12-31	$540,396	10,532	-10.6%	Shares	Sole	2025-01-28
2023-09-30	$684,059	11,786	+6.1%	Shares	Sole	2025-01-28
2023-06-30	$710,292	11,107	+2.6%	Shares	Sole	2025-01-28
2023-03-31	$750,627	10,830	+0.1%	Shares	Sole	2025-01-29
2022-12-31	$778,642	10,822	—	Shares	Sole	2025-01-28
No filing history on record for this holder in this stock.